MedicineBiologyEnvironmental Science

Steven Schwarzbach, Sabir Muzzafar, John Y. Takekawa

2010.10.1CURRENT ALLERGY AND ASTHMA REPORTS

DOI: 10.7589/0090-3558-44.4.1056

Résumé tlooto

It is essential to improve detection methods and stockpile effective antivirals and novel therapeutic modalities, including short-interfering RNAs and new vaccine strategies that use plasmid-based genetic systems, offer promise should a pandemic occur.

Résumé

Avian fl u is infecting mammals and animals as well. The primary source of human infections is direct contact with infected poultry or contaminated environments [2]. Infl uenza A virus may be categorized as avian infl uenza, swine infl uenza, or other animal infl uenza viruses, depending on the hostsource . Examples include subtypes A(H9N2) and A(H5N1) of avian infl uenza “bird fl u” or subtypes A(H3N2) and A(H1N1) of swine infl uenza virus. All these Type A animal infl uenza viruses are different from human infl uenza viruses and do not spread readily among animals. Highly pathogenic avian infl uenza (HPAI) is named poultry viruses that cause severe disease and result in elevated mortality levels. Low pathogenic avian infl uenza (LPAI) is called viruses in poultry that cause mild disease [3].

Format de citation

SCHWARZBACH, Steven; MUZZAFAR, Sabir; TAKEKAWA, John Y. Avian influenza. CURRENT ALLERGY AND ASTHMA REPORTS, 2010, 6: 10–14.